Literature DB >> 21548751

Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. Report of 2 cases.

Shusuke Moriuchi1, Kimito Yamada, Makoto Dehara, Yoshifumi Teramoto, Takao Soda, Masami Imakita, Mamoru Taneda.   

Abstract

5-Aminolevulinic acid (ALA) has been successfully used to confirm the target tumor tissues obtained during stereotactic biopsy. The authors report their experience with 2 patients who underwent stereotactic biopsies of thalamic malignant lymphoma and pontine glioma utilizing 5-ALA. Intraoperatively, the tumor specimens fluoresced, allowing for confirmation that the obtained target specimen contained tumor tissues. No serious side effects or complications occurred.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21548751     DOI： 10.3171/2011.4.JNS102137

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


  9 in total

Review 1.  5ALA in pediatric brain tumors is not routinely beneficial.

Authors:  Jonathan Roth; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2017-03-14       Impact factor: 1.475

2.  Fluorescein-assisted stereotactic needle biopsy of brain tumors: a single-center experience and systematic review.

Authors:  Giuseppe Catapano; Francesco Giovanni Sgulò; Vincenzo Seneca; Giuseppina Iorio; Matteo de Notaris; Giuseppe di Nuzzo
Journal:  Neurosurg Rev       Date:  2018-01-30       Impact factor: 3.042

Review 3.  The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review.

Authors:  Nicholas Ferraro; Eric Barbarite; Trevine R Albert; Emmanuel Berchmans; Ashish H Shah; Amade Bregy; Michael E Ivan; Tyler Brown; Ricardo J Komotar
Journal:  Neurosurg Rev       Date:  2016-01-27       Impact factor: 3.042

Review 4.  Various shades of red-a systematic analysis of qualitative estimation of ALA-derived fluorescence in neurosurgery.

Authors:  Marcel A Kamp; Zarela Krause Molle; Christopher Munoz-Bendix; Marion Rapp; Michael Sabel; Hans-Jakob Steiger; Jan F Cornelius
Journal:  Neurosurg Rev       Date:  2016-05-25       Impact factor: 3.042

5.  5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies.

Authors:  Gord von Campe; Michael Moschopulos; Martin Hefti
Journal:  Acta Neurochir (Wien)       Date:  2012-04       Impact factor: 2.216

6.  5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement.

Authors:  Georg Widhalm; Barbara Kiesel; Adelheid Woehrer; Tatjana Traub-Weidinger; Matthias Preusser; Christine Marosi; Daniela Prayer; Johannes A Hainfellner; Engelbert Knosp; Stefan Wolfsberger
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

Review 7.  Current Trends for Improving Safety of Stereotactic Brain Biopsies: Advanced Optical Methods for Vessel Avoidance and Tumor Detection.

Authors:  Serik K Akshulakov; Talgat T Kerimbayev; Michael Y Biryuchkov; Yermek A Urunbayev; Dara S Farhadi; Vadim A Byvaltsev
Journal:  Front Oncol       Date:  2019-10-02       Impact factor: 6.244

8.  Frameless Stereotactic Biopsy with Intraoperative Computed Tomography "Assessment of Efficacy and Real Target Registration Error".

Authors:  Naokado Ikeda; Yoshihide Katayama; Shinji Kawabata; Motomasa Furuse; Yuichiro Tsuji; Naosuke Nonoguchi; Ryokichi Yagi; Masahiro Kameda; Toshihiro Takami; Toshihiko Kuroiwa; Masahiko Wanibuchi
Journal:  Neurol Med Chir (Tokyo)       Date:  2022-02-22       Impact factor: 2.036

9.  Diagnostic yield of stereotactic needle-biopsies of sub-cubic centimeter intracranial lesions.

Authors:  J Dawn Waters; David D Gonda; Hasini Reddy; Ekkehard M Kasper; Peter C Warnke; Clark C Chen
Journal:  Surg Neurol Int       Date:  2013-04-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.